[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/biz/ - Business & Finance

View post   
File: 11 KB, 400x127, pvct.gif [View same] [iqdb] [saucenao] [google]
257991 No.257991[DELETED]  [Reply] [Original]

would it be a poor choice to buy shares of $PVCT now at 2.69/share and then offload it when it skyrockets right before the April 21st conference?

>> No.258003

what's the dealio with this conference?

>> No.258005

Would it be a poor choice to buy a stock at a low price and sell it at a higher price? I dont know faggot, would it?

>> No.258010

>>258003
well, I just reread the news and apparently they'll release the date of the conference on the 21st.

they're going to release the details of their drug, PV-10, which deals with skin cancer. I'm assuming it can go two ways: another PRAN, or the drug will succeed and PVCT will be bought out by big pharma. however, I'm banking on the hype before the conference to drive the share price up

>> No.258021

>>258010
ah yes, just had a read about it.

"Provectus has recently submitted an application to the FDA for breakthrough therapy designation for PV-10 based on the results from its Phase 2 clinical study related to cutaneous melanoma and is researching its efficacy for other indications."

I'll check it out for sure.

>> No.258019

I got into PVCT back in Jan. at $1.25, sold at $2.67. I would feel comfortable buying it again at low 2s.

>> No.258022

Where do you people even hear of these companies

>> No.258027

the drug will have side effects that won't be known about for 1 week to 3 months. Sell 1 week after the conference

>> No.258028
File: 46 KB, 206x200, 1363996066702.png [View same] [iqdb] [saucenao] [google]
258028

>>258022
what do you mean "you people"?

>> No.258030

>>257991

This is a 'binary event' stock. I don't know that I would trade it, because there's so little news.

Either PV-10 gets approved, or it doesn't.

If it does, a buyout could net shareholders $30-$50 per share.

If it doesn't, it could go to zero. They have no other products in the pipeline.

If you own it, or buy it, you really should be doing so on a belief that PV-10 will warrants buyout by big pharma.

>> No.258035

>>258028

I mean you niggers

nigger

>> No.258048
File: 826 B, 120x160, 1393970160149.gif [View same] [iqdb] [saucenao] [google]
258048

>>258028

>> No.258607

>>258030
so buy calls?

>> No.258720
File: 55 KB, 1013x374, Untitled.png [View same] [iqdb] [saucenao] [google]
258720

OP of first thread a ~week ago. I was just about to make this thread.

There's a chance the BTD will be denied and they'll have to dilute shares and it will fall to $1 and they'll have to do phase 3 trials. However eventually Phase 3 will be approved and this stock will go to $20/share.

>> No.258725
File: 49 KB, 294x294, 1288730114289.jpg [View same] [iqdb] [saucenao] [google]
258725

>>258005

>> No.258780

>>258607

It's an OTC listing, so no options.